ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

BDTX vs VYGR // DIVIDEND YIELD & FCF PAYOUT SAFETY

Black Diamond Therapeutics Inc. (NASDAQ) VS. Voyager Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: BDTX 3 — VYGR 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BDTX VS. VYGR) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC BDTX VYGR SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 10.80% -35.00% +45.80 BDTX /roic <GO>
EV/EBITDA & P/E Valuation 6.9x — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin — -60.00% — TIE /operating-margins <GO>
Net Profit Margin — -60.00% — TIE /net-margins <GO>
Revenue Growth (YoY) — -49.50% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety ACTIVE 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.20 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 5/9 1/9 +4.00 BDTX /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 45.4 31.8 +13.58 BDTX /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $106.9M $108.4M -$1.6M VYGR /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR BDTX REV VYGR REV BDTX GROSS % VYGR GROSS % BDTX FCF VYGR FCF
FY 2025 $0 $40.4M — — $29.6M -$135.1M
FY 2024 $0 $80.0M — — -$62.3M -$18.8M
FY 2023 $0 $250.0M — — -$66.7M $77.9M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BDTX // BETA —
VYGR // BETA —